Decibel Cannabis Company Inc. (TSXV: DB)(OTCQB: DBCCF), a prominent player in premium cannabis and extract products has taken a significant stride in its global expansion strategy.
UK Partnership: A Gateway To European Expansion
The Canadian company has inked a supply agreement with 4C LABS, a leading UK-based healthcare, technology and pharmaceutical firm specializing in cannabis-based medicinal products. This move solidifies Decibel's foothold in the UK market.
Adam Coates, CRO at Decibel, expressed enthusiasm for the collaboration, noting its potential to …